Volume | 2,008 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Amneal Pharmaceuticals Inc | AMRX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
6.21 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
17 | 2,008 | - | 5.01 - 6.46 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
20:14:05 | formt | 100 | US$ 6.45 | USD |
Amneal Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.8B | 307.01M | - | 2.41B | -83.99M | -0.27 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Amneal Pharmaceuticals News
Date | Time | Source | News Article |
---|---|---|---|
25/1/2024 | 23:30 | GlobeNewswire Inc. | Knight Therapeutics Enters into Exclusive License Agreement.. |
10/1/2024 | 23:03 | Edgar (US Regulatory) | Form 8-K - Current report |
06/1/2024 | 08:09 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
04/1/2024 | 08:36 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
04/1/2024 | 08:30 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
Historical AMRX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 5.90 | 6.35 | 5.815 | 6.07 | 1,520,097 | 0.55 | 9.32% |
1 Month | 5.95 | 6.35 | 5.18 | 5.79 | 1,684,371 | 0.50 | 8.40% |
3 Months | 5.47 | 6.46 | 5.01 | 5.77 | 1,632,637 | 0.98 | 17.92% |
6 Months | 5.88 | 6.46 | 5.01 | 5.72 | 1,538,493 | 0.57 | 9.69% |
1 Year | 5.88 | 6.46 | 5.01 | 5.72 | 1,538,493 | 0.57 | 9.69% |
3 Years | 5.88 | 6.46 | 5.01 | 5.72 | 1,538,493 | 0.57 | 9.69% |
5 Years | 5.88 | 6.46 | 5.01 | 5.72 | 1,538,493 | 0.57 | 9.69% |